first large study of glp-1 receptor agonists during pregnancy Maternal cardiometabolic health and the role from preconception to postpartum: A review of evidence and opportunities Continuing Glucagon-Like Peptide-1 Receptor Agonists

The publisher is not affiliated with any brand, company, or trademark owner mentioned unless explicitly stated

Mean weight loss is comparable, 8.5% and 7.1%, respectively

Oral administration is the fastest-growing route, because the traditional delivery method has shown therapeutic benefits

Liraglutide was the first GLP-1 receptor analogue approved for the management of obesity, thus starting the new era of gastrointestinal peptide agonist pharmacotherapy for the treatment of both diabetes and obesity

For many people, weight management is not simply about willpower

Approved obesity drugs have improved upon body weight reduction, but, in part, at the expense of lean muscle